Results 61 to 70 of about 8,860 (154)

Prevalence and Clinical Characteristics of Systemic Sclerosis in Alaska Native and American Indian Peoples in Alaska

open access: yesACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objective Systemic sclerosis (SSc) is known to exhibit significant epidemiologic and clinical variation. This study aimed to describe the clinical and epidemiologic characteristics of SSc in Alaska Native and American Indian (AN/AI) individuals in Alaska.
Vivek R. Mehta   +5 more
wiley   +1 more source

Juvenile Localized Scleroderma. Questions of Treatment

open access: yesВопросы современной педиатрии, 2020
Juvenile localized scleroderma (JLS) is a group of childhood diseases with the main symptom — skin and subcutaneous structures lesions, without any organ involvement. There is active (inflammatory) and fibrotic phase in development of JLS.
Rinat K. Raupov, Mikhail M. Kostik
doaj   +1 more source

A Patient with Localized Scleroderma Successfully Treated with Etretinate

open access: yesCase Reports in Dermatology, 2014
There are several treatment methods for localized scleroderma, but treatment is difficult when the lesion is widely distributed. We encountered a case who was treated successfully with etretinate, a vitamin A derivative.
Tomoko Shima   +3 more
doaj   +1 more source

Recent Advances in Localized Scleroderma

open access: yesSclerosis
Localized scleroderma (LSc), or morphea, is an autoimmune connective tissue disease causing inflammation and fibrosis of the skin and underlying tissues. While distinct from systemic sclerosis, its clinical presentation is highly diverse.
Toshiya Takahashi   +2 more
doaj   +1 more source

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma

open access: yesPediatric Rheumatology Online Journal, 2018
Objectives To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by ...
Anna Agazzi   +4 more
doaj   +1 more source

Parry-Romberg Syndrome Associated with Localized Scleroderma

open access: yesCase Reports in Neurology, 2010
Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is characterized by progressive facial hemiatrophy and frequently overlaps with a condition known as linear scleroderma ‘en coup de sabre’.
Jelena Maletic   +4 more
doaj   +1 more source

Manifestation of morphea in a patient with myasthenia gravis under therapy with zilucoplan

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 249-251, February 2026.
Phoebe Wellmann   +3 more
wiley   +1 more source

A case of localized bullous scleroderma

open access: yesVestnik Dermatologii i Venerologii, 2017
Bullous scleroderma is a rare type of the focal form of the disease mainly affecting the skin and characterized by induration and sclerosis foci as well as subepidermal blisters containing a transparent matter.
A. L. Bakulev   +3 more
doaj   +1 more source

Juvenile localized scleroderma

open access: yesSri Lanka Journal of Child Health, 2019
No abstract available Sri Lanka Journal of Child Health, 2019; 48(4): 364 ...
Luis Zavaleta-Medina   +4 more
openaire   +2 more sources

Experience with Lipofilling in Children with Localized Scleroderma: Case Study

open access: yesВопросы современной педиатрии
Background. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues.
Alina R. Misbakhova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy